Search This Blog

Thursday, November 14, 2019

Stealth BioTherapeutics EPS in-line

Stealth BioTherapeutics (NASDAQ:MITO): Q3 GAAP EPS of -$0.04 in-line.
Cash and cash equivalents of $37.23M.
Press Release
Posted by at

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

Subscribe to: Post Comments (Atom)